TY - CHAP M1 - Book, Section TI - Recurrent Colorectal Cancer A1 - Nadler, Ashlie A1 - Swallow, Carol J. A2 - Morita, Shane Y. A2 - Balch, Charles M. A2 - Klimberg, V. Suzanne A2 - Pawlik, Timothy M. A2 - Posner, Mitchell C. A2 - Tanabe, Kenneth K. PY - 2018 T2 - Textbook of Complex General Surgical Oncology AB - Advances in the treatment of primary rectal cancer, including total mesorectal excision (TME) and neoadjuvant chemoradiation, have reduced the local recurrence (LR) rate to approximately 10% in the modern era.1-3 While the LR rate following resection of rectal cancer significantly exceeded that of colon cancer in older publications, the two are now roughly equivalent.4-6 Given the present incidence of colorectal cancer (CRC) in Western countries of approximately 130,000 cases annually,7 the burden of LR nevertheless remains significant. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesssurgery.mhmedical.com/content.aspx?aid=1145762824 ER -